Top August & September 2021 FDA Approvals
August and September 2021 FDA drug approvals include treatments for tick-borne encephalitis, idiopathic hypersomnia, schizophrenia, and atopic dermatitis.
Psoriasis
Secukinumab vs Adalimumab in Concomitant PsA and Plaque Psoriasis
Secukinumab vs adalimumab for treatment in patients with concomitant plaque psoriasis and active psoriatic arthritis during 52 weeks is reported.
Psoriatic Arthritis Worsens QoL in Psoriasis Patients
Individuals with psoriasis/PsA have decreased ability to participate in social roles and activities, more depression symptoms.
DermDx: Drop-Like Lesions on Back and Chest
A 29-year-old man presents to the dermatology clinic for evaluation of a rash on his body that began 2 weeks ago. Can you make the diagnosis?
Guselkumab Shows Skin Clearance in Psoriasis, Joint Symptom Improvement in Psoriatic Arthritis
At AAD VMX 2021, researchers presented data on skin clearance rates through 5 years with guselkumab in patients with moderate to severe plaque psoriasis.
Bimekizumab Tops Secukinumab for Plaque Psoriasis
In moderate-to-severe plaque psoriasis, bimekizumab is noninferior and superior to secukinumab and adalimumab, according to data from 2 studies.
Premature Mortality Not Associated With Chronic or Increasing Pain Among Patients With Psoriatic Arthritis
Researchers sought to determine if a higher cumulative pain intensity is associated with premature mortality risk in patients with PsA.
Similar Rates of Depression and Anxiety Plus Depression With Apremilast vs Other Drugs in Psoriatic Arthritis
Apremilast used for the treatment of psoriasis or psoriatic arthritis is not associated with a high risk of incident treated depression, anxiety, or anxiety plus depression.
Real-World Study: Guselkumab May Be Effective for Moderate to Severe Plaque Psoriasis
Real-world data from patients with plaque psoriasis treated with guselkumab, who had previously been administered biologic agents is presented.
DermDx: Itchy Patches on the Hands
A 34-year-old man with a 10-year history of a chronic skin condition is referred for evaluation and treatment.
- Loading...
Loading...
Next hm-slideshow in Derm DX
Loading... 
Loading...